Welcoming AI in the Clinical Research Industry

1
Welcoming AI in the Clinical Research Industry
2
Artificial Intelligence (AI) has created a space
for itself in nearly every industry. Due to its
high precision levels and less error-making
tendency, integration of AI has proved that,
along with machine learning algorithms, it can
take the product to its potential with great
efficiency improvement. The healthcare industry,
being one of the most sensitive and responsible
industries, can make use of AI in the refinement
of medical procedures.
Clinical trials using Artificial Intelligence
technology Conventional methods of conducting
clinical trials have reached their limits, which
are observed through delays in clinical trial
outputs, patient retention issues, and their
expensive nature. Artificial Intelligence has the
ability to add to the effectiveness and safety
of clinical trials, with the goal of bringing
optimizations to the processes.
3
Drug testing The drug would be developed using
already available patient data collected through
clinical trials over a period of time. Clinical
trials have the ability to bring down the cost
of clinical trials. Patients can relax knowing
that they will have access to clinical trial
healthcare even if they are not physically
present at the trial site. This would accelerate
the off-site monitoring, especially of weaker
patients that require quarantined
measures. Automations using data analytics An
automated improvement in clinical trials aids in
patient care during clinical trials. All the raw
data would be collected and transformed into
insightful information for the purpose of better
understanding diseases. A few resultant
advancements would include
4
Corrections to recruitment design
inefficiencies, resulting in large- scale
recruitment Precision in evaluation and
definition of data with an increased efficiency
rate against existing information. Having
accessible databases that would keep records of
patient matches on the basis of their health
status and treatment tolerance levels. Helps in
bridging gaps between clinical trial sponsors and
facilities by accelerating business reciprocal
actions.
5
Conclusion There is a wide scope for artificial
intelligence in clinical trials. The clinical
research and clinical trials industry has
expanded beyond its current boundaries with
artificial intelligence. Through the sharing of
relevant information using decentralized clinical
trials, AI could increase the efficiency of
clinical trials while adhering to medical
protocols. Pharmacovigilance courses Regulatory
affairs in clinical research